Member Listing

Name

Richard Kay

Affiliation

Metabolic Research Laboratories

Title

Dr

Role

Post Doctoral

Research Summary

15 years experience at a contract research organisation developing LC-MS methods for quantifying peptides and proteins from pre-clinical and clinical trials supporting biopharmaceutical drug development. Extensive use of triple quadrupole instruments and high resolution mass spectrometers. Development of extraction methods for purifying peptides and proteins from plasma and serum matrices for mass spectrometric analysis. Moved to Cambridge University to set up the peptidomics facility in the Annexe, running a nano flow and high flow rate system linked to a Q-Exactive plus for peptide analysis. The aim of the service is to support the MRL and other groups within Cambridge and further afield with peptidomics studies.

Expertise

Analytical Chemistry

Selected Publications

The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun Mass Spectrom. 2007;21(16):2585-93.

Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. Rapid Commun. Mass Spectrom. 2008; 22: 3255–3260

A novel mass spectrometry-based method for determining insulin-like growth factor 1: assessment in a cohort of subjects with newly diagnosed acromegaly. Clin Endocrinol (Oxf). 2013 Mar;78(3):424-30

Validation of an ultrasensitive LC–MS/MS method for PTH 1–34 in porcine plasma to support a solid dose PK study. Bioanalysis (2015) 7(12), 1435–1445

LC/MS based detection and semi-quantitative analysis of INSL5 in human and murine tissues. Rapid Commun Mass Spectrom. 2017 Aug 31